Bishop, J. R., Najjar, F., Rubin, L. H., Guter, S. J., Owley, T., Mosconi, M. W., . . . Cook, E. H. (2015). Escitalopram pharmacogenetics: CYP2C19 relationships with dosing and clinical outcomes in Autism Spectrum Disorder. Pharmacogenet Genomics.
Chicago Stili AlıntıBishop, Jeffrey R., Fedra Najjar, Leah H. Rubin, Stephen J. Guter, Thomas Owley, Matthew W. Mosconi, Suma Jacob, ve Edwin H. Cook. "Escitalopram Pharmacogenetics: CYP2C19 Relationships With Dosing and Clinical Outcomes in Autism Spectrum Disorder." Pharmacogenet Genomics 2015.
MLA AlıntıBishop, Jeffrey R., et al. "Escitalopram Pharmacogenetics: CYP2C19 Relationships With Dosing and Clinical Outcomes in Autism Spectrum Disorder." Pharmacogenet Genomics 2015.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..